The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

Elan Pharmaceuticals competitive analysis

Loading summary...

Latest patents of Elan Pharmaceuticals opposed by its competitors

Explore Elan Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 13, 2025
Patent NumberPublication DateTitleTotal Oppositions
EP2645106
Oct 2, 2024Methods And Products For Evaluating An Immune Response To A Therapeutic Agent1
EP1793855
Jan 19, 2022Prevention And Treatment Of Synucleinopathic And Amyloidogenic Disease1
EP1991267
Dec 20, 2017Methods Of Treating Inflammatory And Autoimmune Diseases With Natalizumab1

Latest PTAB cases involving Elan Pharmaceuticals

Discover the latest PTAB cases involving Elan Pharmaceuticals, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Elan Pharmaceuticals with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 13, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
ELAN PHARMACEUTICALS - 3 - -
MATHYS & SQUIRE54 - - -
PHARMACEUTICAL WORKS POLPHARMA3 - - -